GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension
This cohort study analyzes electronic health record data for patients with idiopathic intracranial hypertension to assess whether therapy with glucagon-like peptide 1 receptor agonists is associated with improved clinical outcomes compared with conventional therapies.